Immediate Impact
7 from Science/Nature 60 standout
Citing Papers
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Antisense technology: A review
2021 Standout
Works of Hal Hirte being referenced
A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hal Hirte | 139 | 72 | 149 | 9 | 309 | |
| Felicity Lose | 124 | 34 | 112 | 17 | 302 | |
| Terrence J. Colgan | 93 | 64 | 144 | 7 | 332 | |
| Mojca Persic | 140 | 161 | 102 | 11 | 331 | |
| Luisa Carrara | 162 | 124 | 92 | 11 | 362 | |
| Eamonn O’Brien | 127 | 103 | 87 | 12 | 285 | |
| Alba Mota | 51 | 40 | 218 | 13 | 352 | |
| Jane Cipollone | 94 | 93 | 139 | 8 | 282 | |
| Tricia Murdock | 57 | 69 | 133 | 15 | 357 | |
| L. Edwards | 140 | 102 | 136 | 7 | 357 | |
| Federica Predolini | 143 | 65 | 77 | 12 | 267 |
All Works
Loading papers...